Ranchers Vets Embrace $4 Treatment to Beat Screwworm
A low-cost $4 treatment is gaining traction as a flesh-eating screwworm reemerges in U.S. livestock. Ranchers and vet...
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesA low-cost $4 treatment is gaining traction as a flesh-eating screwworm reemerges in U.S. livestock. Ranchers and vet...
As AI accelerates, Microsoft reports robust AI-driven revenue while stock faces capex-related volatility. This piece ...
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...
Korean equities ended a choppy week higher after reports that Anthropic and Samsung were in talks. The move capped a ...
Jim Cramer argues that Google could win the AI war by leveraging Apple’s massive device base, a move that could redef...
Tesla faces a pivotal Q2 print as shares struggle in 2026. While deliveries rose, investors will be watching margins,...
Keysight Technologies surged to an all-time high after posting a stronger-than-expected Q1 FY2026, driven by AI infra...
JPMorgan Chase CEO Jamie Dimon cautions that inflation could reappear if geopolitical shocks linger, rattling investo...
Investors are watching after reports that Mojtaba Khamenei could become Iran’s next supreme leader. The potential mov...
Goldman Sachs now puts a one-year recession probability at about 25%. Here’s how that signal, plus energy volatility ...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
U.S. stocks fell on Friday as energy prices rose and inflation fears persisted, setting the stage for a fifth straigh...